CRISPR/Cas9 Market Report

China CRISPR/Cas9 Industry Market Research Report 2023-2029

  • POSTDATE：Oct 08, 2023
  • PAGES：231
  • REPORT CODE：GMM1838698
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • CRISPR is a family of DNA sequences found within the genomes of prokaryotic organisms such as bacteria and archaea. These sequences are derived from DNA fragments from viruses that have previously infected the prokaryote and are used to detect and destroy DNA from similar viruses during subsequent infections. Hence these sequences play a key role in the antiviral defense system of prokaryotes.  Cas9 is an enzyme that uses CRISPR sequences as a guide to recognize and cleave specific strands of DNA that are complementary to the CRISPR sequence. Cas9 enzymes together with CRISPR sequences form the basis of a technology known as CRISPR/Cas9 that can be used to edit genes within organisms. This type of gene editing process has a wide variety of applications including use as a basic biology research tool, development of biotechnology products, and potentially to treat diseases.

    This report elaborates on the current development of the CRISPR/Cas9 industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Integrated DNA Technologies (IDT)

    • GeneCopoeia

    • Cellecta

    • Caribou Biosciences

    • Horizon Discovery Group

    • Intellia Therapeutics

    • Merck

    • Editas Medicine

    • Synthego

    • Agilent Technologies

    • Mirus Bio

    • GenScript

    • Takara Bio

    By Type:

    • Genetically Modified Organisms/Crops

    • Human Stem Cells

    • gRNA Database/Gene Librar

    • Genome Editing

    • CRISPR Plasmid

    • Genetic engineering

    • Cell Line Engineering

    By Application:

    • Academic Institutes

    • Biotechnology Companies

    • Pharmaceutical Companies

    • Research and Development Institutes

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China CRISPR/Cas9 Market Overview 2018-2029

    • 1.1 China CRISPR/Cas9 Industry Development Overview

    • 1.2 China CRISPR/Cas9 Industry Development History

    • 1.3 China CRISPR/Cas9 Industry Market Size (2018-2029)

    • 1.4 China CRISPR/Cas9 Market Analysis by Type from Production Side

      • 1.4.1 China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Genetically Modified Organisms/Crops (2018-2029)

      • 1.4.2 China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Human Stem Cells (2018-2029)

      • 1.4.3 China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of gRNA Database/Gene Librar (2018-2029)

      • 1.4.4 China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Genome Editing (2018-2029)

      • 1.4.5 China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of CRISPR Plasmid (2018-2029)

      • 1.4.6 China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Genetic engineering (2018-2029)

      • 1.4.7 China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Cell Line Engineering (2018-2029)

    • 1.5 China CRISPR/Cas9 Market Analysis by Application from Consumption End

      • 1.5.1 China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Academic Institutes (2018-2029)

      • 1.5.2 China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Biotechnology Companies (2018-2029)

      • 1.5.3 China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)

      • 1.5.4 China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Research and Development Institutes (2018-2029)

    • 1.6 China CRISPR/Cas9 Market Analysis by Region

      • 1.6.1 North China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    Chapter 2 China CRISPR/Cas9 Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on CRISPR/Cas9 Market Status and Competition at home and abroad in 2023

      • 2.2.2 China CRISPR/Cas9 Market Status and Competition Analysis in 2023

      • 2.2.3 China CRISPR/Cas9 Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China CRISPR/Cas9 Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on CRISPR/Cas9 Industry Development

    Chapter 3 CRISPR/Cas9Industry Chain Analysis

    • 3.1 CRISPR/Cas9 Industry Chain

    • 3.2 CRISPR/Cas9 Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the CRISPR/Cas9 Market

    • 3.3 CRISPR/Cas9 Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the CRISPR/Cas9 Market

    Chapter 4 China CRISPR/Cas9 Market, by Type

    • 4.1 China CRISPR/Cas9 Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China CRISPR/Cas9 Total Production Volume and Growth Rate from Production Side

    • 4.5 China CRISPR/Cas9 Production Volume and Growth Rate, by Type

      • 4.5.1 China CRISPR/Cas9 Production Volume and Growth Rate of Genetically Modified Organisms/Crops

      • 4.5.2 China CRISPR/Cas9 Production Volume and Growth Rate of Human Stem Cells

      • 4.5.3 China CRISPR/Cas9 Production Volume and Growth Rate of gRNA Database/Gene Librar

      • 4.5.4 China CRISPR/Cas9 Production Volume and Growth Rate of Genome Editing

      • 4.5.5 China CRISPR/Cas9 Production Volume and Growth Rate of CRISPR Plasmid

      • 4.5.6 China CRISPR/Cas9 Production Volume and Growth Rate of Genetic engineering

      • 4.5.7 China CRISPR/Cas9 Production Volume and Growth Rate of Cell Line Engineering

    Chapter 5 China CRISPR/Cas9 Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China CRISPR/Cas9 Total Market Size and Growth Rate from Consumption End

    • 5.5 China CRISPR/Cas9 Market Size and Growth Rate, by Application

      • 5.5.1 China CRISPR/Cas9 Market Size and Growth Rate of Academic Institutes

      • 5.5.2 China CRISPR/Cas9 Market Size and Growth Rate of Biotechnology Companies

      • 5.5.3 China CRISPR/Cas9 Market Size and Growth Rate of Pharmaceutical Companies

      • 5.5.4 China CRISPR/Cas9 Market Size and Growth Rate of Research and Development Institutes

    Chapter 6 China CRISPR/Cas9 Market, by Region

    • 6.1 China CRISPR/Cas9 Production Volume and Production Value, by Region

    • 6.2 China CRISPR/Cas9 Sales Volume and Sales Value, by Region

    Chapter 7 North China CRISPR/Cas9 Market Analysis

    • 7.1 North China CRISPR/Cas9 Market, by Type

    • 7.2 North China CRISPR/Cas9 Market, by Application

    Chapter 8 Central China CRISPR/Cas9 Market Analysis

    • 8.1 Central China CRISPR/Cas9 Market, by Type

    • 8.2 Central China CRISPR/Cas9 Market, by Application

    Chapter 9 South China CRISPR/Cas9 Market Analysis

    • 9.1 South China CRISPR/Cas9 Market, by Type

    • 9.2 South China CRISPR/Cas9 Market, by Application

    Chapter 10 East China CRISPR/Cas9 Market Analysis

    • 10.1 East China CRISPR/Cas9 Market, by Type

    • 10.2 East China CRISPR/Cas9 Market, by Application

    Chapter 11 Northeast China CRISPR/Cas9 Market Analysis

    • 11.1 Northeast China CRISPR/Cas9 Market, by Type

    • 11.2 Northeast China CRISPR/Cas9 Market, by Application

    Chapter 12 Southwest China CRISPR/Cas9 Market Analysis

    • 12.1 Southwest China CRISPR/Cas9 Market, by Type

    • 12.2 Southwest China CRISPR/Cas9 Market, by Application

    Chapter 13 Northwest China CRISPR/Cas9 Market Analysis

    • 13.1 Northwest China CRISPR/Cas9 Market, by Type

    • 13.2 Northwest China CRISPR/Cas9 Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Integrated DNA Technologies (IDT)

        • 14.1.1 Integrated DNA Technologies (IDT) Company Profile

        • 14.1.2 Integrated DNA Technologies (IDT) CRISPR/Cas9 Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 GeneCopoeia

        • 14.2.1 GeneCopoeia Company Profile

        • 14.2.2 GeneCopoeia CRISPR/Cas9 Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Cellecta

        • 14.3.1 Cellecta Company Profile

        • 14.3.2 Cellecta CRISPR/Cas9 Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Caribou Biosciences

        • 14.4.1 Caribou Biosciences Company Profile

        • 14.4.2 Caribou Biosciences CRISPR/Cas9 Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Horizon Discovery Group

        • 14.5.1 Horizon Discovery Group Company Profile

        • 14.5.2 Horizon Discovery Group CRISPR/Cas9 Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Intellia Therapeutics

        • 14.6.1 Intellia Therapeutics Company Profile

        • 14.6.2 Intellia Therapeutics CRISPR/Cas9 Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Merck

        • 14.7.1 Merck Company Profile

        • 14.7.2 Merck CRISPR/Cas9 Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Editas Medicine

        • 14.8.1 Editas Medicine Company Profile

        • 14.8.2 Editas Medicine CRISPR/Cas9 Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Synthego

        • 14.9.1 Synthego Company Profile

        • 14.9.2 Synthego CRISPR/Cas9 Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Agilent Technologies

        • 14.10.1 Agilent Technologies Company Profile

        • 14.10.2 Agilent Technologies CRISPR/Cas9 Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Mirus Bio

        • 14.11.1 Mirus Bio Company Profile

        • 14.11.2 Mirus Bio CRISPR/Cas9 Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 GenScript

        • 14.12.1 GenScript Company Profile

        • 14.12.2 GenScript CRISPR/Cas9 Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Takara Bio

        • 14.13.1 Takara Bio Company Profile

        • 14.13.2 Takara Bio CRISPR/Cas9 Market Performance

        • 14.13.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 CRISPR/Cas9 Industry Research Conclusions

    • 15.2 CRISPR/Cas9 Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China CRISPR/Cas9 Industry Market Size (2018-2029)

    • Figure China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Genetically Modified Organisms/Crops (2018-2029)

    • Figure China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Human Stem Cells (2018-2029)

    • Figure China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of gRNA Database/Gene Librar (2018-2029)

    • Figure China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Genome Editing (2018-2029)

    • Figure China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of CRISPR Plasmid (2018-2029)

    • Figure China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Genetic engineering (2018-2029)

    • Figure China CRISPR/Cas9 Production Volume, Production Value and Growth Rate of Cell Line Engineering (2018-2029)

    • Figure China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Academic Institutes (2018-2029)

    • Figure China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Biotechnology Companies (2018-2029)

    • Figure China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Pharmaceutical Companies (2018-2029)

    • Figure China CRISPR/Cas9 Sales Volume, Sales Value and Growth Rate of Research and Development Institutes (2018-2029)

    • Figure North China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    • Figure Central China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    • Figure South China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    • Figure East China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    • Figure Northeast China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    • Figure Southwest China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    • Figure Northwest China CRISPR/Cas9 Market Size and Growth Rate from 2018-2029

    • Figure CRISPR/Cas9 Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China CRISPR/Cas9 Market Share by Type in 2018

    • Figure China CRISPR/Cas9 Market Share by Type in 2023

    • Figure China CRISPR/Cas9 Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume and Growth Rate of Genetically Modified Organisms/Crops (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume and Growth Rate of Human Stem Cells (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume and Growth Rate of gRNA Database/Gene Librar (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume and Growth Rate of Genome Editing (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume and Growth Rate of CRISPR Plasmid (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume and Growth Rate of Genetic engineering (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume and Growth Rate of Cell Line Engineering (2018-2023)

    • Figure China CRISPR/Cas9 Market Share by Application in 2018

    • Figure China CRISPR/Cas9 Market Share by Application in 2023

    • Figure China CRISPR/Cas9 Total Market Size and Growth Rate from Consumption End

    • Figure China CRISPR/Cas9 Market Size and Growth Rate of Academic Institutes (2018-2023)

    • Figure China CRISPR/Cas9 Market Size and Growth Rate of Biotechnology Companies (2018-2023)

    • Figure China CRISPR/Cas9 Market Size and Growth Rate of Pharmaceutical Companies (2018-2023)

    • Figure China CRISPR/Cas9 Market Size and Growth Rate of Research and Development Institutes (2018-2023)

    • Table China CRISPR/Cas9 Production Volume by Region (2018-2023)

    • Table China CRISPR/Cas9 Production Volume Share by Region (2018-2023)

    • Figure China CRISPR/Cas9 Production Volume Share by Region (2018-2023)

    • Table China CRISPR/Cas9 Production Value by Region (2018-2023)

    • Table China CRISPR/Cas9 Production Value Share by Region (2018-2023)

    • Figure China CRISPR/Cas9 Production Value Share by Region (2018-2023)

    • Table China CRISPR/Cas9 Sales Volume by Region (2018-2023)

    • Table China CRISPR/Cas9 Sales Volume Share by Region (2018-2023)

    • Figure China CRISPR/Cas9 Sales Volume Share by Region (2018-2023)

    • Table China CRISPR/Cas9 Sales Value by Region (2018-2023)

    • Table China CRISPR/Cas9 Sales Value Share by Region (2018-2023)

    • Figure China CRISPR/Cas9 Sales Value Share by Region (2018-2023)

    • Table North China CRISPR/Cas9 Production Volume by Type (2018-2023)

    • Table North China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Figure North China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Table North China CRISPR/Cas9 Sales Volume by Application (2018-2023)

    • Table North China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Figure North China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Table Central China CRISPR/Cas9 Production Volume by Type (2018-2023)

    • Table Central China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Figure Central China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Table Central China CRISPR/Cas9 Sales Volume by Application (2018-2023)

    • Table Central China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Figure Central China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Table South China CRISPR/Cas9 Production Volume by Type (2018-2023)

    • Table South China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Figure South China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Table South China CRISPR/Cas9 Sales Volume by Application (2018-2023)

    • Table South China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Figure South China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Table East China CRISPR/Cas9 Production Volume by Type (2018-2023)

    • Table East China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Figure East China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Table East China CRISPR/Cas9 Sales Volume by Application (2018-2023)

    • Table East China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Figure East China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Table Northeast China CRISPR/Cas9 Production Volume by Type (2018-2023)

    • Table Northeast China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Figure Northeast China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Table Northeast China CRISPR/Cas9 Sales Volume by Application (2018-2023)

    • Table Northeast China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Figure Northeast China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Table Southwest China CRISPR/Cas9 Production Volume by Type (2018-2023)

    • Table Southwest China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Figure Southwest China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Table Southwest China CRISPR/Cas9 Sales Volume by Application (2018-2023)

    • Table Southwest China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Figure Southwest China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Table Northwest China CRISPR/Cas9 Production Volume by Type (2018-2023)

    • Table Northwest China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Figure Northwest China CRISPR/Cas9 Production Volume Share by Type (2018-2023)

    • Table Northwest China CRISPR/Cas9 Sales Volume by Application (2018-2023)

    • Table Northwest China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Figure Northwest China CRISPR/Cas9 Sales Volume Share by Application (2018-2023)

    • Table Integrated DNA Technologies (IDT) Company Profile

    • Table Integrated DNA Technologies (IDT) CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table GeneCopoeia Company Profile

    • Table GeneCopoeia CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Cellecta Company Profile

    • Table Cellecta CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Caribou Biosciences Company Profile

    • Table Caribou Biosciences CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Horizon Discovery Group Company Profile

    • Table Horizon Discovery Group CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Intellia Therapeutics Company Profile

    • Table Intellia Therapeutics CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Merck Company Profile

    • Table Merck CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Editas Medicine Company Profile

    • Table Editas Medicine CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Synthego Company Profile

    • Table Synthego CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies Company Profile

    • Table Agilent Technologies CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Mirus Bio Company Profile

    • Table Mirus Bio CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table GenScript Company Profile

    • Table GenScript CRISPR/Cas9 Revenue, Price and Gross (2018-2023)

    • Table Takara Bio Company Profile

    • Table Takara Bio CRISPR/Cas9 Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US